Let’s start up with the current stock price of ENDRA Life Sciences Inc. (NDRA), which is $0.81 to be very precise. The Stock rose vividly during the last session to $0.94 after opening rate of $0.90 while the lowest price it went was recorded $0.7703 before closing at $0.90.
Recently in News on December 15, 2020, ENDRA Life Sciences Announces Proposed Public Offering of Common Stock. ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. ENDRA expects to grant the underwriter a 45-day option to purchase additional shares of common stock offered in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
ENDRA Life Sciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.2500 on 01/06/20, with the lowest value was $0.5990 for the same time period, recorded on 04/06/20.
ENDRA Life Sciences Inc. (NDRA) full year performance was -21.41%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ENDRA Life Sciences Inc. shares are logging -63.78% during the 52-week period from high price, and 36.04% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.60 and $2.25.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1042335 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ENDRA Life Sciences Inc. (NDRA) recorded performance in the market was -51.49%, having the revenues showcasing 0.60% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 20.00M, as it employees total of 15 workers.
Market experts do have their say about ENDRA Life Sciences Inc. (NDRA)
During the last month, 0 analysts gave the ENDRA Life Sciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8105, with a change in the price was noted -0.2251. In a similar fashion, ENDRA Life Sciences Inc. posted a movement of -21.64% for the period of last 100 days, recording 250,831 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NDRA is recording 0.09 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.09.
Technical breakdown of ENDRA Life Sciences Inc. (NDRA)
Raw Stochastic average of ENDRA Life Sciences Inc. in the period of last 50 days is set at 55.29%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 34.16%. In the last 20 days, the company’s Stochastic %K was 58.78% and its Stochastic %D was recorded 64.73%.
Bearing in mind the latest performance of ENDRA Life Sciences Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -51.49%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -25.92%, alongside a downfall of -21.41% for the period of the last 12 months. The shares increased approximately by -3.98% in the 7-day charts and went down by -3.45% in the period of the last 30 days. Common stock shares were driven by 0.60% during last recorded quarter.